Adam D. Matherly

Adam D. Matherly is an Associate in the firm’s Business & Finance practice group.  He provides counsel to emerging and established companies in connection with business structuring and reorganizations; mergers and acquisitions; trademarks, copyrights, and other intellectual property protection; and licensing and other commercial transactions.  Adam’s practice includes the representation of buyers and sellers in connection with private security offerings.  He is also a member of the firm’s Cannabis practice group, representing Washington-licensed producers and processors, as well as non-licensed businesses which service the legal cannabis industry.

Prior to joining Karr Tuttle Campbell, Adam managed his own law firm where he served as outside corporate counsel for a number of biotech, e-commerce, manufacturing, and distribution companies.  Concurrently, he managed the daily operations of a client aerospace tooling company as its Vice-President and COO.

Adam received his J.D. from Santa Clara University where he was an Associate of the Computer & High Tech Law Journal and Vice-President of the Biotech Law Group.  He received a B.S. in Bioengineering from the University of Washington, completing his capstone project on the modeling of drug-drug interactions under Dr. Paolo Vicini and Dr. Wendy Thomas.  Before receiving his law degree, Adam worked as a legal intern and research scientist at several biotech and pharmaceutical companies.

Outside of his work as an attorney, Adam works as a consultant for several nonprofit organizations.  He also serves as an officer and business manager for a variety of outside entrepreneurial ventures.

• Intellectual Property
• Business & Finance
• Emerging Company & Venture Capital

• Washington State Bar Association
• King County Bar Association

• J.D., Santa Clara University
  • Associate, Computer & High Tech Law Journal
  • Vice-President, Biotech Law Group
• B.S., University of Washington

• Washington State Bar